Targeting Amyloid Fibrils by Passive Immunotherapy in Systemic Amyloidosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting Amyloid Fibrils by Passive Immunotherapy in Systemic Amyloidosis

Published:2022-09 Issue:5 Volume:36 Page:591-608
ISSN:1173-8804
Container-title:BioDrugs
language:en
Short-container-title:BioDrugs

Author:

Nuvolone Mario^ORCID,Nevone Alice^ORCID,Merlini Giampaolo^ORCID

Funder

Ministero della Salute

Fondazione Cariplo

Associazione Italiana per la Ricerca sul Cancro

Università degli Studi di Pavia

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine,Biotechnology

Link

https://link.springer.com/content/pdf/10.1007/s40259-022-00550-w.pdf

Reference73 articles.

1. Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med. 2003;349(6):583–96. https://doi.org/10.1056/NEJMra023144.

2. Merlini G, Dispenzieri A, Sanchorawala V, et al. Systemic immunoglobulin light chain amyloidosis. Nat Rev Dis Primers. 2018;4(1):38. https://doi.org/10.1038/s41572-018-0034-3.

3. Shi J, Guan J, Jiang B, et al. Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38alpha MAPK pathway. Proc Natl Acad Sci U S A. 2010;107(9):4188–93. https://doi.org/10.1073/pnas.0912263107.

4. Lavatelli F, Imperlini E, Orru S, et al. Novel mitochondrial protein interactors of immunoglobulin light chains causing heart amyloidosis. FASEB J. 2015;29(11):4614–28. https://doi.org/10.1096/fj.15-272179.

5. Brenner DA, Jain M, Pimentel DR, et al. Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress. Circ Res. 2004;94(8):1008–10.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delayed identification of monoclonal protein is associated with early death in isolated cardiac AL amyloidosis;Amyloid;2024-07-02

2. Renale Amyloidosen;Nephrologie aktuell;2024-07

3. Systemic Light Chain Amyloidosis;New England Journal of Medicine;2024-06-27

4. Current Therapies and Future Horizons in Cardiac Amyloidosis Treatment;Current Heart Failure Reports;2024-05-29

5. Outcomes of Modified Mayo Stage IIIa and IIIb Cardiac Light-Chain Amyloidosis: Real-World Experience in Clinical Characteristics and Treatment—67 Patients Multicenter Analysis;Cancers;2024-04-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3